Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | MEF2A |
| Upstream (Parents) |
|---|
| (<<) CHSY1 → MEF2A |
| (<<) CISH → MEF2A |
| (<<) CYB561D1 → MEF2A |
| (<<) IL1A → MEF2A |
| (<<) ITGB8 → MEF2A |
| (<<) JAK2 → MEF2A |
| (<<) LYPLA2 → MEF2A |
| (<<) NFAT5 → MEF2A |
| (<<) PIK3C2B → MEF2A |
| (<<) PIK3R2 → MEF2A |
| (<<) PLOD2 → MEF2A |
| (<<) SLC25A37 → MEF2A |
| (<<) TPM1 → MEF2A |
| (<<) UBE2D3 → MEF2A |
| (<<) VIM → MEF2A |
| Downstream (Children) |
|---|
| MEF2A → BMP2 (>>) |
| MEF2A → CCDC88A (>>) |
| MEF2A → CCNL1 (>>) |
| MEF2A → DNM3 (>>) |
| MEF2A → FBXO32 (>>) |
| MEF2A → FOXC2 (>>) |
| MEF2A → GNB4 (>>) |
| MEF2A → GOT2 (>>) |
| MEF2A → KREMEN2 (>>) |
| MEF2A → MAP2K5 (>>) |
| MEF2A → MKNK1 (>>) |
| MEF2A → MMP15 (>>) |
| MEF2A → PRKAA1 (>>) |
